Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?

References

• KetelaarsCASchlösserMAMostertRDeterminants of health-related quality of life in patients with chronic obstructive pulmonary diseaseThorax19965139438658367
   PubMed Web of Science ®Google Scholar
• Ebi-KrystonKLRespiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall studyJ Clin Epidemiol198842512603339378
   PubMed Web of Science ®Google Scholar
• TockmanMSComstockGWRespiratory risk factors and mortality: longitudinal studies in Washington County, MarylandAm Rev Respir Dis19891403 Pt 2S56S632782761
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summaryAm J Respir Crit Care Med201318734736522878278
   PubMed Web of Science ®Google Scholar
• TsujiTAoshibaKNagaiAAlveolar cell senescence in patients with pulmonary emphysemaAm J Respir Crit Care Med200617488689316888288
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
   PubMed Web of Science ®Google Scholar
• VestboJAgustiAWoutersEFEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Study InvestigatorsShould we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study teamAm J Respir Crit Care Med20141891022103024552242
   PubMed Web of Science ®Google Scholar
• StockleyRAProteases and Antiproteases in Chronic Obstructive Pulmonary Disease: Pathogenesis to TreatmentChadwickDGoodeJAWileyChichester, UK2001189204
   Google Scholar
• The Alpha-l-Antitrypsin Deficiency Registry Study GroupSurvival and FEVl decline in individuals with severe deficiency of alpha-l antitrypsinAm J Respir Crit Care Med199815849599655706
   PubMed Web of Science ®Google Scholar
• SeersholmNWenckerMBanikNDoes alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study groupEur Respir J199710226022639387950
   PubMed Web of Science ®Google Scholar
• ChapmanKRStockleyRADawkinsCAugmentation therapy for alpha1 antitrypsin deficiency: a meta-analysisCOPD2009617718419811373
   PubMedGoogle Scholar
• AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA1994272149715057966841
   PubMed Web of Science ®Google Scholar
• American Thoracic Society; European Respiratory SocietyAmerican Thoracic Society/European Respiratory Society Statement: standards for the diagnosis and management of individuals with alpha1-antitrypsin deficiencyAm J Respir Crit Care Med200316881890014522813
   PubMed Web of Science ®Google Scholar
• StockleyRAMiravitllesMVogelmeierCAugmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approachOrphanet J Rare Dis2013814924063809
   PubMed Web of Science ®Google Scholar
• BTS/ARTP guidelinesGuidelines for the measurement of respiratory functionResp Med199488165194
   Google Scholar
• DawkinsPADawkinsCLWoodAMRate of progression of lung function impairment in alpha-1 antitrypsin deficiencyEur Respir J2009331338134419164359
   PubMed Web of Science ®Google Scholar
• QuanjerPHTammelingGJCotesJELung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory SocietyEur Respir J19931654024576915
   PubMed Web of Science ®Google Scholar
• PillaiAPTurnerAMStockleyRARelationship of the 2011 Global Initiative for Chronic Obstructive Lung Disease strategy to clinically relevant outcomes in individuals with α1-antitrypsin deficiencyAnn Am Thoracic Soc201411859864
   Google Scholar
• WenckerMFuhrmannBBanikNLongitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitorChest200111973774411243951
   PubMed Web of Science ®Google Scholar
• ParrDGStoelBCStolkJPattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairmentAm J Respir Crit Care Med20041701172117815306534
   PubMed Web of Science ®Google Scholar
• ParrDGSevenoaksMDengCDetection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advancesRespir Res20081392118271964
   PubMed Web of Science ®Google Scholar
• TantucciCModinaDLung function decline in COPDInt J Chron Obstruct Pulmon Dis20127959922371650
   PubMed Web of Science ®Google Scholar
• WangMLAvahiaBHPetsonkELInterpreting periodic lung function tests in individuals: the relationship between 1- to 5-year and long-term FEV1 changesChest200613049349916899850
   PubMed Web of Science ®Google Scholar
• StolkJPutterHBakkerEMProgression parameters for emphysema: a clinical investigationRespir Med20071011924193017644366
   PubMed Web of Science ®Google Scholar
• DowsonLJGuestPJHillSLHigh-resolution computed tomography scanning in a1-antitrypsin deficiency: relationship to lung function and health statusEur Respir J2001171097110411491150
   PubMed Web of Science ®Google Scholar
• DawkinsPADowsonLJGuestPJPredictors of mortality in – antitrypsin deficiencyThorax2003581020102614645964
   PubMed Web of Science ®Google Scholar
• ParrDGStoelBCStolkJValidation of computed tomographic lung densitometry for monitoring emphysema in a-1-antitrypsin deficiencyThorax20066148549016537666
   PubMed Web of Science ®Google Scholar
• StolkJStockleyRAPiitulainenERelationship between change in lung density and long-term progression of lung functionAm J Respir Crit Care Med201519211411626131993
   PubMed Web of Science ®Google Scholar
• GreenCEParrDGEdgarRGStockleyRATurnerAMLung density associates with survival in alpha 1 antitrypsin deficient patientsRespir Med2016112818726874894
   PubMed Web of Science ®Google Scholar
• DirksenADijkmanJHMadsenFA randomized clinical trial of alpha-1-antitrypsin augmentation therapyAm J Respir Crit Care Med19991601468147210556107
   PubMed Web of Science ®Google Scholar
• DirksenAPiitulainenEParrDGExploring the role of CT densitometry: a randomised study of augmentation therapy in alpha-1-antitrypsin deficiencyEur Respir J2009331345135319196813
   PubMed Web of Science ®Google Scholar
• ChapmanKRBurdonJGWPiitulainenEIntravenous augmentation treatment and lung density in severe a1 antitrypsin deficiency (RAPID): a randomised, double blind, placebo controlled trialLancet201538636036826026936
   PubMed Web of Science ®Google Scholar